Skip to main content

Table 3 Baseline characteristics of patients between WBRT+boost and SRS alone after propensity score matching

From: Whole brain radiation therapy plus focal boost may be a suitable strategy for brain metastases in SCLC patients: a multi-center study

 

WBRT + boost

SRS Alone

P-Value

(n = 37)

(n = 37)

Age, No. (%)

  

1.00

 < 60

14

14

 

 ≥60

23

23

 

Sex, No. (%)

  

0.407

 Male

27

30

 

 Female

10

7

 

KPS, No. (%)

  

0.815

 ≤80

20

21

 

 > 80

17

16

 

Number of BMs, No. (%)

  

0.744

 1–3

31

32

 

 > 3

6

5

 

Maximum size of BM, No. (%)

  

0.642

 < 20 mm

18

20

 

 ≧20 mm

19

17

 

Extracranial metastases, No. (%)

  

0.317

 Yes

2

6

 

 None

6

6

 

 Unknown

29

25

 

Symptoms of BM, No. (%)

  

0.809

 Yes

14

13

 

 None

23

24

 

Systematic treatment

  

0.802

 CTx

26

25

 

 No-CTx

11

12

 
  1. Abbreviations: WBRT+boost whole brain radiotherapy plus focal radiation boost, SRS stereotactic radiosurgery, KPS Karnofsky Performance Status, BM brain metastasis, CTx chemotherapy, No-CTx no chemotherapy
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us